
Sign up to save your podcasts
Or


This week please join author Yugo Yamashita and Associate Editor Joshua Beckman as they discuss the article "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20250303.648421
By Greg Hundley, MD and Peder Myhre, MD, PhD4.3
3030 ratings
This week please join author Yugo Yamashita and Associate Editor Joshua Beckman as they discuss the article "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20250303.648421

133 Listeners

319 Listeners

502 Listeners

167 Listeners

902 Listeners

298 Listeners

3,384 Listeners

138 Listeners

1,143 Listeners

194 Listeners

90 Listeners

521 Listeners

367 Listeners

440 Listeners

376 Listeners